Ankita Leekha

Employment

• University of Houston Research Assistant Professor
  2026 - Present
• University of Houston Post Doctoral Fellow
  2018 - 2026

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (24)

• Therapeutic intranasal delivery of NanoSTING provides broad protection against seasonal and highly pathogenic influenza strains
  Antiviral Research 2026 DOI: 10.1016/j.antiviral.2026.106342
  +Save
• Assessment of the biocompatibility and biodistribution of fluorescent oleic acid capped ZnSe/CdS/ core shell quantum dots after intravenous injection in Balb/c mice
  Bioimpacts 2025 DOI: 10.34172/bi.30467
  +Save
• Mucosal Vaccines with Sting-Agonist Liposomal Formulations Inhibit Rsv (Respiratory Syncytial Virus) Replication in Cotton Rats
  Ssrn 2025 DOI: 10.2139/ssrn.5093718
  +Save
• Mucosal vaccines with STING-agonist liposomal formulations inhibit RSV (respiratory syncytial virus) replication in cotton rats
  Vaccine 2025 DOI: 10.1016/j.vaccine.2025.127183
  +Save
• An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models
  Nature Communications 2024 DOI: 10.1038/s41467-024-50234-y
  +Save
• An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis
  Vaccine 2024 DOI: 10.1016/j.vaccine.2024.04.055
  +Save
• Enzymatic depletion of circulating glutamine is immunosuppressive in cancers
  iScience 2024 DOI: 10.1016/j.isci.2024.109817
  +Save
• Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
  Nature Communications 2024 DOI: 10.1038/s41467-024-50133-2
  +Save
• An intranasal nanoparticle STING agonist has broad protective immunity against respiratory viruses and variants
  bioRxiv 2022 DOI: 10.1101/2022.04.18.488695
  +Save
• Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine
  bioRxiv 2022 DOI: 10.1101/2022.07.14.500068
  +Save